HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO BRAIN NATRIURETIC PEPTIDE INFUSION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:393
作者
YOSHIMURA, M
YASUE, H
MORITA, E
SAKAINO, N
JOUGASAKI, M
KUROSE, M
MUKOYAMA, M
SAITO, Y
NAKAO, K
IMURA, H
机构
[1] KUMAMOTO UNIV,SCH MED,DIV CARDIOL,1-1-1 HONJO,KUMAMOTO 860,JAPAN
[2] NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 565,JAPAN
[3] KYOTO UNIV,SCH MED,DEPT MED,DIV 2,KYOTO 606,JAPAN
关键词
ATRIAL NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CONGESTIVE HEART FAILURE; NATRIURESIS;
D O I
10.1161/01.CIR.84.4.1581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study was designed to examine the hemodynamic, renal, and hormonal effects of brain natriuretic peptide (BNP) infusion in patients with congestive heart failure (CHF) and in control subjects. Methods and Results. We infused synthetic human BNP at a rate of 0.1-mu-g/kg/min. BNP infusion decreased pulmonary capillary wedge pressure (control, from 5 +/- 1 to 2 +/- 1 mm Hg, p < 0.01; CHF, from 21 +/- 3 to 14 +/- 4 mm Hg, p < 0.05) and systemic vascular resistance (control, from 1,264 +/- 75 to 934 +/- 52 dyne.sec.cm-5; CHF, from 2,485 +/- 379 to 1,771 +/- 195 dyne.sec.cm-5; p < 0.01, respectively) and increased stroke volume index (control, from 49.9 +/- 2.7 to 51.5 +/- 2.3 ml/m2, p = NS; CHF, from 25.6 +/- 3.8 to 32.0 +/- 3.9 ml/m2, p < 0.01). BNP infusion significantly increased urine volume (control, from 2.3 +/- 0.7 to 7.5 +/- 1.9 ml/min; CHF, from 0.8 +/- 0.2 to 5.3 +/- 1.0 ml/min; p < 0.01, respectively), excretion of sodium (control, from 79.2 +/- 21.6 to 332.8 +/- 70.9-mu-Eq/min; CHF, from 77.4 +/- 20.8 to 753.5 +/- 108.0-mu-Eq/min; p < 0.01, respectively), and excretion of chloride (control, from 72.5 +/- 18.4 to 256.0 +/- 43.3-mu-Eq/min; CHF, from 74.0 +/- 19.6 to 708.8 +/- 103.3-mu-Eq/min; p < 0.01, respectively). Urinary excretion of sodium and of chloride in response to BNP infusion was higher in patients with CHF than in control subjects (p < 0.01, respectively). BNP infusion increased the levels of plasma atrial natriuretic peptide (control, from 65 +/- 11 to 84 +/- 14 pg/ml; CHF, from 262 +/- 65 to 301 +/- 62 pg/ml; p < 0.05, respectively) and decreased plasma aldosterone concentrations in both groups (control, from 43.3 +/- 12.1 to 27.3 +/- 7.1 pg/ml; CHF, from 91.1 +/- 34.3 to 66.3 +/- 27.2 pg/ml; p < 0.05, respectively). Conclusions. We conclude that BNP infusion improves left ventricular function in patients with CHF by vasodilation and prominent natriuretic action.
引用
收藏
页码:1581 / 1588
页数:8
相关论文
共 50 条
[31]   ATRIAL-NATRIURETIC-FACTOR AFTER DOPAMINE INFUSION IN HEALTHY-SUBJECTS AND IN CONGESTIVE-HEART-FAILURE [J].
FONTANA, F ;
BERNARDI, P ;
RUFFINI, M ;
CAPELLI, M .
EUROPEAN HEART JOURNAL, 1991, 12 (07) :803-806
[32]   Brain natriuretic peptide: A diagnostic and treatment hormone for perioperative congestive heart failure [J].
Skidmore, KL ;
Russell, IA .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2004, 18 (06) :780-787
[33]   Brain natriuretic peptide - the biological marker in the diagnosis of overt congestive heart failure and myocardial ischemia [J].
Lisy, M. ;
Babal, P. .
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2007, 108 (4-5) :170-173
[34]   Correlative Study on TCM Syndromes of Congestive Heart Failure, Cardiac Function and Brain Natriuretic Peptide [J].
Li Xiaoqian ;
He Jiancheng ;
Fu Deyu ;
Cao Xuebin ;
Shen Lin ;
Hu Dongpei .
2013 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2013,
[35]   CONSISTENT CHANGES IN THE CIRCADIAN-RHYTHMS OF BLOOD-PRESSURE AND ATRIAL-NATRIURETIC-PEPTIDE IN CONGESTIVE-HEART-FAILURE [J].
PORTALUPPI, F ;
MONTANARI, L ;
FERLINI, M ;
VERGNANI, L ;
DAMBROSI, A ;
CAVALLINI, AR ;
BAGNI, B ;
UBERTI, ED .
CHRONOBIOLOGY INTERNATIONAL, 1991, 8 (05) :432-439
[36]   Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide) [J].
Iglesias, Jose ;
Hom, Deborah ;
Antoniotti, Maria ;
Ayoub, Sammy ;
Levine, Jerrold S. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (12) :3458-3465
[37]   Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure [J].
Kato, M ;
Kinugawa, T ;
Ogino, K ;
Endo, A ;
Osaki, S ;
Igawa, O ;
Hisatome, I ;
Shigemasa, C .
JOURNAL OF INTERNAL MEDICINE, 2000, 248 (04) :309-315
[38]   INTERPRETATION OF PLASMA-CONCENTRATIONS OF HUMAN ATRIAL-NATRIURETIC-PEPTIDE (HANP) IN CONGESTIVE-HEART-FAILURE [J].
HARTTER, E ;
WEISSEL, M ;
PUNZENGRUBER, C ;
BURGHUBER, OC ;
WOLOSZCZUK, W .
ACTA MEDICA AUSTRIACA, 1990, 17 (04) :71-77
[39]   ACUTE HEMODYNAMIC-EFFECTS OF LISINOPRIL AND CAPTOPRIL IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE [J].
VANMIEGHEM, W ;
VANHEDENT, T ;
BYTTEBIER, G .
ACTA CARDIOLOGICA, 1993, 48 (01) :43-53
[40]   Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure [J].
Tamura, K ;
Takahashi, N ;
Nakatani, Y ;
Onishi, S ;
Iwasaka, T .
GERONTOLOGY, 2001, 47 (01) :46-51